Company · CIK 2035832

# Aktis Oncology, Inc.

| CIK | [2035832](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002035832) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | AKTS (Nasdaq) |
| First annual or quarterly report | 2026-03-30 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-292283 | IPO Final prospectus | 2025-12-19 | 2026-01-09 | 5 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-01-09 | [424B4](https://www.sec.gov/Archives/edgar/data/2035832/000119312526009078/0001193125-26-009078-index.htm) Final prospectus | 333-292283 | 0001193125-26-009078 |
| 2026-01-08 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2035832/999999999526000113/9999999995-26-000113-index.htm) Declared effective | 333-292283 | 9999999995-26-000113 |
| 2026-01-07 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2035832/000119312526005437/0001193125-26-005437-index.htm) Amendment | 333-292283 | 0001193125-26-005437 |
| 2026-01-05 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2035832/000119312526001466/0001193125-26-001466-index.htm) Amendment | 333-292283 | 0001193125-26-001466 |
| 2025-12-19 | [S-1](https://www.sec.gov/Archives/edgar/data/2035832/000119312525326780/0001193125-25-326780-index.htm) Registration filed | 333-292283 | 0001193125-25-326780 |
| 2024-10-11 | [DRS](https://www.sec.gov/Archives/edgar/data/2035832/000095012324009664/0000950123-24-009664-index.htm) Draft made public | 377-07497 | 0000950123-24-009664 |

[All filings of this company](https://equitycapital.markets/filings?cik=2035832) · [CSV](https://equitycapital.markets/filings.csv?cik=2035832)

---
Source page: https://equitycapital.markets/company/2035832 · Data: U.S. SEC EDGAR · CC BY 4.0